Less than 10°c was recorded in Telangana after a few days of rise in the temperatures. While 9.2°c was recorded in Sirpur of Kumuram Bheem Asifabad and 9.6°c was recorded in Bheempur of ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Many ...

Federal prosecutors allege that he sexually abused women and coerced them into drug-fuelled sex parties using threats and violence. He has denied all charges, and his criminal trial is currently ...

A Yolngu man who recently had his eyesight restored after nearly a decade of vision impairment is encouraging others in his community to seek eye care. Find out why. For nearly a decade, Uncle ...

The FDA granted 510(k) clearance for the VIA360 surgical system, which is designed to deliver viscoelastic fluid during ophthalmic surgeries, according to a press release from New World Medical.

Alnylam has said it will not proceed with a clinical trial of its RNAi drug vutrisiran in the rare eye disorder Stargardt disease – at least for now – tying its decision to President Joe Biden ...

Final results of the OCEAN(a)-DOSE trial – published in the New England Journal of Medicine – showed that the small, interfering RNA (siRNA) drug reduced Lp(a) levels compared to placebo at ...

The risk of systemic side effects is greater in infants than in adults due to increased percutaneous drug absorption and lower blood volume. The closed eyes technique of eyedrop administration is ...

Luke Daugherty is a freelance writer, editor and former operations manager. His work covers operations, marketing, sustainable business and personal finance, as well as many of his personal ...

Compr Ophthalmol Update. 2005;6(2):85-101. Antimicrobial medications for conjunctivitis are typically given as one drop (or one-half inch of ointment) four times daily for 5-7 days. Ointments have ...

MediPrint's LL-BMT1 contact lens offers a sustained drug delivery system, potentially improving glaucoma treatment compliance and reducing dosing frequency. The Phase 2b trial showed LL-BMT1's ...